A microbiologist is involved in research on the emergence of a novel virus, X, which caused a recent epidemic in his community. After studying the structure of the virus, he proposes a hypothesis: Virus X developed from viruses A and B. He suggests that viruses A and B could co-infect a single host cell. During the growth cycles of the viruses within the cells, a new virion particle is formed, which contains the genome of virus A; however, its coat contains components of the coats of both viruses A and B. This new virus is identical to virus X, which caused the epidemic. Which of the following phenomena is reflected in the hypothesis proposed by the microbiologist?
Q2
A 37-year-old woman with a history of anorectal abscesses complains of pain in the perianal region. Physical examination reveals mild swelling, tenderness, and erythema of the perianal skin. She is prescribed oral ampicillin and asked to return for follow-up. Two days later, the patient presents with a high-grade fever, syncope, and increased swelling. Which of the following would be the most common mechanism of resistance leading to the failure of antibiotic therapy in this patient?
Q3
A 42-year-old woman with a history of multiple sclerosis and recurrent urinary tract infections comes to the emergency department because of flank pain and fever. Her temperature is 38.8°C (101.8°F). Examination shows left-sided costovertebral angle tenderness. She is admitted to the hospital and started on intravenous vancomycin. Three days later, her symptoms have not improved. Urine culture shows growth of Enterococcus faecalis. Which of the following best describes the most likely mechanism of antibiotic resistance in this patient?
Q4
An 18-year old college freshman presents to his university clinic because he has not been feeling well for the past two weeks. He has had a persistent headache, occasional cough, and chills without rigors. The patient’s vital signs are normal and physical exam is unremarkable. His radiograph shows patchy interstitial lung infiltrates and he is diagnosed with atypical pneumonia. The patient is prescribed azithromycin and takes his medication as instructed. Despite adherence to his drug regimen, he returns to the clinic one week later because his symptoms have not improved. The organism responsible for this infection is likely resistant to azithromycin through which mechanism?
Q5
An investigator is studying bacterial toxins in a nonpathogenic bacterial monoculture that has been inoculated with specific bacteriophages. These phages were previously cultured in a toxin-producing bacterial culture. After inoculation, a new toxin is isolated from the culture. Genetic sequencing shows that the bacteria have incorporated viral genetic information, including the gene for this toxin, into their genome. The described process is most likely responsible for acquired pathogenicity in which of the following bacteria?
Q6
You are treating a neonate with meningitis using ampicillin and a second antibiotic, X, that is known to cause ototoxicity. What is the mechanism of antibiotic X?
Q7
A 63-year-old man with aortic valve disease is admitted to the hospital for a 3-week history of progressively worsening fatigue, fever, and night sweats. He does not smoke, drink alcohol, or use illicit drugs. Temperature is 38.2°C (100.8°F). Physical examination shows a systolic murmur and tender, erythematous nodules on the finger pads. Blood cultures show alpha-hemolytic, gram-positive cocci that are catalase-negative and optochin-resistant. Which of the following is the most likely causal organism?
Q8
The lac operon allows E. coli to effectively utilize lactose when it is available, and not to produce unnecessary proteins. Which of the following genes is constitutively expressed and results in the repression of the lac operon?
Q9
An investigator is studying human genetics and cell division. A molecule is used to inhibit the exchange of genetic material between homologous chromosomes. Which of the following phases of the cell cycle does the molecule target?
Q10
A 29-year-old pregnant woman with no prior antibiotic exposure presents with gonorrhea. Culture of Neisseria gonorrhoeae shows resistance to penicillin, tetracycline, and fluoroquinolones. Genetic testing reveals she has a strain with chromosomal mutations in penA (mosaic allele), mtrR promoter, and gyrA. She reports her partner recently returned from Southeast Asia. Apply epidemiologic and resistance mechanism knowledge to determine the most appropriate management and public health action.
Transposons and integrons US Medical PG Practice Questions and MCQs
Question 1: A microbiologist is involved in research on the emergence of a novel virus, X, which caused a recent epidemic in his community. After studying the structure of the virus, he proposes a hypothesis: Virus X developed from viruses A and B. He suggests that viruses A and B could co-infect a single host cell. During the growth cycles of the viruses within the cells, a new virion particle is formed, which contains the genome of virus A; however, its coat contains components of the coats of both viruses A and B. This new virus is identical to virus X, which caused the epidemic. Which of the following phenomena is reflected in the hypothesis proposed by the microbiologist?
A. Complementation
B. Phenotypic mixing (Correct Answer)
C. Genetic reassortment
D. Genetic recombination
E. Antigenic shift
Explanation: ***Phenotypic mixing***
- Involves the **packaging of the genome of one virus type into a capsid** that contains proteins from another virus type or a mosaic of proteins from both types.
- The new virion (Virus X) has the **genome of virus A** but a **coat with components from both A and B**, which is the hallmark of phenotypic mixing.
*Complementation*
- Occurs when one virus provides a **missing gene product** (e.g., an enzyme or structural protein) that allows a co-infecting, functionally deficient virus to replicate.
- In complementation, the progeny viruses typically retain their original genetic material and coat proteins, unlike the described scenario where the coat is mixed.
*Genetic reassortment*
- Applies to viruses with **segmented genomes**, where entire gene segments are exchanged between different viral strains co-infecting the same cell.
- This results in progeny viruses with a **novel combination of gene segments**, altering both the genome and potentially the viral proteins; the scenario described involves a mixed coat, not a whole genome segment exchange.
*Genetic recombination*
- Involves the **physical exchange of genetic material between two different viruses** during co-infection, leading to progeny viruses with a new combination of genes within a single genome.
- This creates permanent changes in the viral genome, whereas **phenotypic mixing is typically a transient phenomenon** affecting only the virion's physical structure, not its inherited genetic information.
*Antigenic shift*
- Refers to a **major change in the influenza virus genome** due to genetic reassortment, resulting in a novel hemagglutinin or neuraminidase protein.
- It leads to a **new subtype of the virus** with high pandemic potential, but it is a specific example of genetic reassortment, not the general phenomenon described.
Question 2: A 37-year-old woman with a history of anorectal abscesses complains of pain in the perianal region. Physical examination reveals mild swelling, tenderness, and erythema of the perianal skin. She is prescribed oral ampicillin and asked to return for follow-up. Two days later, the patient presents with a high-grade fever, syncope, and increased swelling. Which of the following would be the most common mechanism of resistance leading to the failure of antibiotic therapy in this patient?
A. Intrinsic absence of a target site for the drug
B. Use of an altered metabolic pathway
C. Production of beta-lactamase enzyme (Correct Answer)
D. Altered structural target for the drug
E. Drug efflux pump
Explanation: ***Production of beta-lactamase enzyme***
- The patient's symptoms of a rapidly worsening infection despite ampicillin treatment suggest the presence of a **beta-lactamase producing organism**. Ampicillin is a **beta-lactam antibiotic** that is inactivated by these enzymes.
- Anorectal abscesses and rapidly progressing soft tissue infections are often caused by **polymicrobial flora**, including staphylococci and enterococci, many of which can produce **beta-lactamase**.
*Intrinsic absence of a target site for the drug*
- While some bacteria inherently lack the target site for certain drugs (e.g., mycoplasma lacking a cell wall, thus being resistant to beta-lactams), this is less likely to be the **most common mechanism of acquired resistance** leading to treatment failure in a typical perianal infection.
- The rapid progression and failed initial treatment point towards an **acquired mechanism of resistance** rather than an intrinsic one.
*Use of an altered metabolic pathway*
- This mechanism, such as altered **folate synthesis pathways** in resistance to trimethoprim-sulfamethoxazole, is less common as the primary mechanism for ampicillin resistance.
- Ampicillin's mechanism of action primarily targets the **bacterial cell wall**, not a metabolic pathway in the same way.
*Altered structural target for the drug*
- This involves modifications to the **penicillin-binding proteins (PBPs)**, which are the targets of beta-lactam antibiotics like ampicillin. While a valid mechanism (e.g., in MRSA), the **production of beta-lactamase** is generally a more widespread and common cause of ampicillin failure, especially in infections involving mixed flora from the perianal region.
- Given the abrupt failure of ampicillin, **beta-lactamase inactivation** is a more immediate and common cause than a rapid mutational change in PBPs.
*Drug efflux pump*
- **Efflux pumps** actively remove antibiotics from the bacterial cell, contributing to resistance against various drug classes.
- While efflux pumps can play a role, the dominant mechanism for resistance to **ampicillin** in many common perianal pathogens is the **enzymatic degradation by beta-lactamases**.
Question 3: A 42-year-old woman with a history of multiple sclerosis and recurrent urinary tract infections comes to the emergency department because of flank pain and fever. Her temperature is 38.8°C (101.8°F). Examination shows left-sided costovertebral angle tenderness. She is admitted to the hospital and started on intravenous vancomycin. Three days later, her symptoms have not improved. Urine culture shows growth of Enterococcus faecalis. Which of the following best describes the most likely mechanism of antibiotic resistance in this patient?
A. Increased efflux across bacterial cell membranes
B. Production of beta-lactamase
C. Alteration of penicillin-binding proteins
D. Alteration of peptidoglycan synthesis (Correct Answer)
E. Alteration of ribosomal targets
Explanation: ***Alteration of peptidoglycan synthesis***
- **Vancomycin** targets the **D-Ala-D-Ala terminus** on the peptidoglycan precursor, preventing cross-linking during bacterial cell wall synthesis.
- **Vancomycin resistance in Enterococcus faecalis** occurs through acquisition of resistance genes (vanA, vanB) that encode enzymes modifying the peptidoglycan precursor from **D-Ala-D-Ala to D-Ala-D-Lac**.
- This structural change reduces vancomycin's binding affinity by approximately 1000-fold, rendering the antibiotic ineffective.
- The mechanism directly involves **alteration of the peptidoglycan synthesis pathway**, specifically the terminal amino acid residues of the pentapeptide precursor.
*Increased efflux across bacterial cell membranes*
- This mechanism involves **efflux pumps that actively transport antibiotics out of the bacterial cell**, reducing intracellular concentration.
- While efflux pumps contribute to resistance for antibiotics like **tetracyclines, fluoroquinolones, and macrolides**, this is not the primary mechanism of vancomycin resistance in Enterococcus.
*Production of beta-lactamase*
- **Beta-lactamase enzymes** hydrolyze the **beta-lactam ring** of antibiotics like **penicillins and cephalosporins**, rendering them inactive.
- **Vancomycin is a glycopeptide antibiotic, not a beta-lactam**, so its efficacy is not affected by beta-lactamase production.
*Alteration of ribosomal targets*
- This mechanism confers resistance to antibiotics that target **bacterial ribosomes** to inhibit protein synthesis, such as **macrolides, aminoglycosides, and tetracyclines**.
- **Vancomycin acts on cell wall synthesis**, not protein synthesis, so alteration of ribosomal targets is not relevant to vancomycin resistance.
*Alteration of penicillin-binding proteins*
- **Penicillin-binding proteins (PBPs)** are the targets of **beta-lactam antibiotics** (penicillins, cephalosporins, carbapenems).
- Alterations in PBPs cause resistance to beta-lactams, not to vancomycin.
- **Vancomycin does not interact with PBPs**; it binds directly to the D-Ala-D-Ala terminus of peptidoglycan precursors in the cell wall.
Question 4: An 18-year old college freshman presents to his university clinic because he has not been feeling well for the past two weeks. He has had a persistent headache, occasional cough, and chills without rigors. The patient’s vital signs are normal and physical exam is unremarkable. His radiograph shows patchy interstitial lung infiltrates and he is diagnosed with atypical pneumonia. The patient is prescribed azithromycin and takes his medication as instructed. Despite adherence to his drug regimen, he returns to the clinic one week later because his symptoms have not improved. The organism responsible for this infection is likely resistant to azithromycin through which mechanism?
A. Mutation in topoisomerase II
B. Methylation of ribosomal binding site
C. Presence of a beta-lactamase
D. Decreased binding to RNA polymerase
E. Insertion of drug efflux pumps (Correct Answer)
Explanation: ***Insertion of drug efflux pumps***
- **Azithromycin** is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit**.
- In **Mycoplasma pneumoniae** (the most common cause of atypical pneumonia in young adults), the **most common** mechanism of macrolide resistance is through **efflux pumps**, particularly the **mef genes**.
- These efflux pumps actively transport macrolides out of the bacterial cell, reducing intracellular drug concentration and conferring resistance.
- This mechanism is responsible for the majority of macrolide-resistant *M. pneumoniae* isolates worldwide.
*Methylation of ribosomal binding site*
- **Methylation** of the ribosomal binding site (specifically the **23S rRNA** via erm genes) does prevent azithromycin from binding effectively.
- While this is a valid macrolide resistance mechanism seen in organisms like *Streptococcus pneumoniae* and *Streptococcus pyogenes*, it is **less common** in *Mycoplasma pneumoniae*.
- Efflux pumps (mef) are the predominant mechanism in *M. pneumoniae* resistant strains.
*Mutation in topoisomerase II*
- **Topoisomerase II** (DNA gyrase) is the target of **fluoroquinolone antibiotics**, not macrolides.
- Mutations in this enzyme lead to resistance against fluoroquinolones, such as **ciprofloxacin**.
*Presence of a beta-lactamase*
- **Beta-lactamase enzymes** inactivate **beta-lactam antibiotics** (e.g., penicillin, cephalosporins) by hydrolyzing their beta-lactam ring.
- Additionally, *Mycoplasma pneumoniae* **lacks a cell wall**, making it inherently resistant to all beta-lactam antibiotics regardless of beta-lactamase production.
*Decreased binding to RNA polymerase*
- **RNA polymerase** is the target for antibiotics like **rifampin**, which inhibits bacterial transcription.
- Decreased binding to RNA polymerase would lead to rifampin resistance, not azithromycin resistance.
Question 5: An investigator is studying bacterial toxins in a nonpathogenic bacterial monoculture that has been inoculated with specific bacteriophages. These phages were previously cultured in a toxin-producing bacterial culture. After inoculation, a new toxin is isolated from the culture. Genetic sequencing shows that the bacteria have incorporated viral genetic information, including the gene for this toxin, into their genome. The described process is most likely responsible for acquired pathogenicity in which of the following bacteria?
A. Staphylococcus aureus
B. Haemophilus influenzae
C. Neisseria meningitidis
D. Streptococcus pneumoniae
E. Corynebacterium diphtheriae (Correct Answer)
Explanation: ***Corynebacterium diphtheriae***
- The process described, where a bacterium acquires new genetic information (e.g., a toxin gene) from a bacteriophage, is called **lysogenic conversion** or **phage conversion**. *Corynebacterium diphtheriae* is the **classic example** of this mechanism, acquiring its toxigenicity through phage-mediated transfer of the **diphtheria toxin gene (tox gene)** via bacteriophage β.
- The diphtheria toxin is an **AB toxin** that ADP-ribosylates and thereby inactivates **elongation factor 2 (EF-2)**, inhibiting host cell protein synthesis and leading to the characteristic symptoms of diphtheria.
- This is the **prototypical and most clinically significant example** of lysogenic conversion in medical microbiology.
*Staphylococcus aureus*
- While *Staphylococcus aureus* can acquire some virulence factors via bacteriophages (e.g., **Panton-Valentine leukocidin**, some enterotoxins), many of its toxins are encoded on **mobile genetic elements** such as plasmids, pathogenicity islands, or chromosomal genes.
- However, *S. aureus* is **not the classic example** of lysogenic conversion described in this scenario. *C. diphtheriae* better exemplifies the acquisition of a major toxin exclusively through phage conversion.
*Haemophilus influenzae*
- *Haemophilus influenzae* primarily causes disease through its **polysaccharide capsule** (especially type b) and is a common cause of respiratory infections and meningitis.
- Its major virulence factors are typically chromosomally encoded or acquired through **transformation** (uptake of naked DNA), not through phage conversion for a primary toxin.
*Neisseria meningitidis*
- *Neisseria meningitidis* causes meningococcal disease, primarily due to its **polysaccharide capsule** and **endotoxin (LPS)**.
- While genetic exchange can occur, the acquisition of a major toxin gene by phage conversion as described is not a primary mechanism for its key virulence factors.
*Streptococcus pneumoniae*
- *Streptococcus pneumoniae* is a leading cause of pneumonia, meningitis, and otitis media, with its main virulence factor being its **polysaccharide capsule**.
- It primarily acquires genetic material through **transformation** (competence-mediated uptake of naked DNA), which contributes to antibiotic resistance and capsule types, but lysogenic conversion with toxin acquisition is not typical for its major virulence factors.
Question 6: You are treating a neonate with meningitis using ampicillin and a second antibiotic, X, that is known to cause ototoxicity. What is the mechanism of antibiotic X?
A. It binds the 50S ribosomal subunit and inhibits formation of the initiation complex
B. It binds the 30S ribosomal subunit and inhibits formation of the initiation complex (Correct Answer)
C. It binds the 30S ribosomal subunit and reversibly inhibits translocation
D. It binds the 50S ribosomal subunit and inhibits peptidyltransferase
E. It binds the 50S ribosomal subunit and reversibly inhibits translocation
Explanation: ***It binds the 30s ribosomal subunit and inhibits formation of the initiation complex***
- The second antibiotic, X, is likely an **aminoglycoside**, such as **gentamicin** or **amikacin**, which are commonly used in combination with ampicillin for neonatal meningitis and are known to cause ototoxicity.
- Aminoglycosides exert their bactericidal effect by **irreversibly binding to the 30S ribosomal subunit**, thereby **inhibiting the formation of the initiation complex** and leading to misreading of mRNA.
*It binds the 50S ribosomal subunit and inhibits formation of the initiation complex*
- This mechanism is characteristic of **linezolid**, which targets the 50S ribosomal subunit to prevent the formation of the initiation complex.
- While linezolid can cause side effects, **ototoxicity** is less commonly associated with it compared to aminoglycosides, and it is not a primary drug for neonatal meningitis alongside ampicillin.
*It binds the 50S ribosomal subunit and inhibits peptidyltransferase*
- This is the mechanism of action for **chloramphenicol**, which inhibits **peptidyltransferase** activity on the 50S ribosomal subunit, preventing peptide bond formation.
- Although chloramphenicol can cause **ototoxicity** and **aplastic anemia**, its use in neonates is limited due to the risk of **Gray Baby Syndrome**.
*It binds the 30s ribosomal subunit and reversibly inhibits translocation*
- This describes the mechanism of action of **tetracyclines**, which reversibly bind to the 30S ribosomal subunit and prevent the attachment of aminoacyl-tRNA, thereby inhibiting protein synthesis.
- Tetracyclines are **contraindicated in neonates** due to their potential to cause **tooth discoloration** and **bone growth inhibition**, and ototoxicity is not their primary adverse effect.
*It binds the 50s ribosomal subunit and reversibly inhibits translocation*
- This mechanism of reversibly inhibiting translocation by binding to the 50S ribosomal subunit is characteristic of **macrolides** (e.g., erythromycin, azithromycin) and **clindamycin**.
- While some macrolides can cause **transient ototoxicity**, they are not typically the second antibiotic of choice for neonatal meningitis in combination with ampicillin, and clindamycin's side effect profile is different.
Question 7: A 63-year-old man with aortic valve disease is admitted to the hospital for a 3-week history of progressively worsening fatigue, fever, and night sweats. He does not smoke, drink alcohol, or use illicit drugs. Temperature is 38.2°C (100.8°F). Physical examination shows a systolic murmur and tender, erythematous nodules on the finger pads. Blood cultures show alpha-hemolytic, gram-positive cocci that are catalase-negative and optochin-resistant. Which of the following is the most likely causal organism?
A. Streptococcus pneumoniae
B. Staphylococcus epidermidis
C. Viridans streptococci (Correct Answer)
D. Streptococcus pyogenes
E. Streptococcus gallolyticus
Explanation: ***Viridans streptococci***
- The patient's presentation with **subacute onset** of fever, fatigue, cardiac murmur, and **Osler nodes** (tender finger nodules) points to **infective endocarditis**. The micro-organism is described as **alpha-hemolytic**, **catalase-negative**, and **optochin-resistant**, which are characteristic features of **Viridans streptococci**.
- **Viridans streptococci** are a common cause of **subacute bacterial endocarditis**, especially in patients with pre-existing valvular disease like the **aortic valve disease** mentioned.
*Streptococcus pneumoniae*
- While **Streptococcus pneumoniae** is also **alpha-hemolytic** and **catalase-negative**, it is typically **optochin-sensitive** and a common cause of **pneumonia** and **meningitis**, not usually subacute endocarditis from oral flora.
- Endocarditis caused by *S. pneumoniae* is rare and usually associated with a more fulminant course.
*Staphylococcus epidermidis*
- **Staphylococcus epidermidis** is a **coagulase-negative staphylococcus** that is a common cause of **prosthetic valve endocarditis** and is **catalase-positive**, unlike the organism described here.
- It is not typically alpha-hemolytic.
*Streptococcus pyogenes*
- **Streptococcus pyogenes** is **beta-hemolytic** and **catalase-negative**, and typically causes **pharyngitis** and **skin infections**, or sometimes **acute endocarditis**.
- It does not fit the description of an **alpha-hemolytic**, **optochin-resistant** organism.
*Streptococcus gallolyticus*
- **Streptococcus gallolyticus** (formerly *Streptococcus bovis*) is associated with **bacteremia** and **endocarditis**, particularly in patients with **gastrointestinal malignancies**.
- While it is **alpha-hemolytic** and **catalase-negative**, it is typically differentiated by its growth in **bile esculin** and is not primarily defined by optochin resistance characteristic of Viridans group.
Question 8: The lac operon allows E. coli to effectively utilize lactose when it is available, and not to produce unnecessary proteins. Which of the following genes is constitutively expressed and results in the repression of the lac operon?
A. LacY
B. LacI (Correct Answer)
C. LacZ
D. CAP
E. LacA
Explanation: ***LacI***
- The **LacI gene** encodes the **Lac repressor protein**, which is constitutively expressed (always produced) and binds to the operator region of the lac operon.
- When bound, the **Lac repressor** blocks RNA polymerase from transcribing the structural genes (LacZ, LacY, LacA), thereby repressing the operon in the absence of lactose.
*LacY*
- The **LacY gene** encodes **lactose permease**, an enzyme responsible for transporting lactose into the bacterial cell.
- Its expression is regulated by the lac operon and is not constitutively expressed; rather, it is induced in the presence of lactose.
*LacZ*
- The **LacZ gene** encodes **beta-galactosidase**, the enzyme that breaks down lactose into glucose and galactose.
- Like LacY, its expression is part of the lac operon and is induced when lactose is available, not expressed constitutively.
*CAP*
- **CAP (Catabolite Activator Protein)** is a regulatory protein that, when bound to cAMP, activates transcription of the lac operon when glucose is absent.
- While essential for lac operon regulation, CAP is not a gene whose constitutive expression leads to repression of the operon.
*LacA*
- The **LacA gene** encodes **thiogalactoside transacetylase**, an enzyme with a less clear role in lactose metabolism but is part of the lac operon.
- Its expression is also regulated and induced along with LacZ and LacY, not constitutively expressed to repress the operon.
Question 9: An investigator is studying human genetics and cell division. A molecule is used to inhibit the exchange of genetic material between homologous chromosomes. Which of the following phases of the cell cycle does the molecule target?
A. Prophase II
B. Prophase I (Correct Answer)
C. Metaphase II
D. Telophase I
E. Anaphase I
Explanation: ***Prophase I***
- **Crossing over** (genetic recombination) occurs specifically during **Prophase I** of meiosis, particularly during the pachytene stage
- During this phase, homologous chromosomes pair up (synapsis) and exchange genetic material through recombination
- Inhibiting this exchange means targeting the phase where this critical genetic recombination takes place
*Prophase II*
- Prophase II is a stage in meiosis II where chromosomes condense again after a brief interkinesis
- **Crossing over does not occur** in Prophase II - genetic recombination has already been completed in Prophase I
- Homologous chromosomes are no longer paired at this stage
*Metaphase II*
- During Metaphase II, individual chromosomes (not homologous pairs) align along the metaphase plate
- There is **no exchange of genetic material** between homologous chromosomes at this stage
- This phase prepares for the separation of sister chromatids
*Telophase I*
- Telophase I involves decondensation of chromosomes and reformation of nuclear envelopes around the separated homologous chromosomes
- This marks the end of meiosis I, **after** genetic exchange has already occurred in Prophase I
- No crossing over occurs during this phase
*Anaphase I*
- In Anaphase I, **homologous chromosomes separate** and move to opposite poles of the cell
- This phase is characterized by segregation of chromosomes, **not genetic exchange**
- Crossing over has already been completed by this stage
Question 10: A 29-year-old pregnant woman with no prior antibiotic exposure presents with gonorrhea. Culture of Neisseria gonorrhoeae shows resistance to penicillin, tetracycline, and fluoroquinolones. Genetic testing reveals she has a strain with chromosomal mutations in penA (mosaic allele), mtrR promoter, and gyrA. She reports her partner recently returned from Southeast Asia. Apply epidemiologic and resistance mechanism knowledge to determine the most appropriate management and public health action.
A. Treat with ceftriaxone alone and report to local health department
B. Treat with dual therapy (ceftriaxone plus azithromycin) and initiate partner notification with travel history documentation (Correct Answer)
C. Perform cephalosporin susceptibility testing before treatment initiation
D. Treat with azithromycin monotherapy due to pregnancy
E. Initiate spectinomycin therapy and routine partner notification only
Explanation: ***Treat with dual therapy (ceftriaxone plus azithromycin) and initiate partner notification with travel history documentation***
- The presence of the **mosaic penA allele** and **mtrR promoter mutations** signifies significant resistance potential; **dual therapy** with ceftriaxone and azithromycin remains critical for ensuring cure and slowing further resistance in highly resistant strains.
- Given the partner's travel to **Southeast Asia**, a region known for emerging **extensively drug-resistant (XDR)** gonorrhea, documenting travel and notification is vital for public health **surveillance**.
*Treat with ceftriaxone alone and report to local health department*
- While ceftriaxone is the backbone of treatment, using **monotherapy** for a strain already exhibiting multiple chromosomal resistance mutations (mosaic penA) increases the risk of selecting for **cephalosporin resistance**.
- This approach is less robust than dual therapy in the context of suspected **imported resistant strains** from high-risk geographic regions.
*Perform cephalosporin susceptibility testing before treatment initiation*
- Delaying treatment for **Neisseria gonorrhoeae** waiting for susceptibility results is inappropriate as it allows for ongoing **transmission** and potential progression to **pelvic inflammatory disease**.
- Clinical guidelines recommend **empiric treatment** based on local prevalence and travel history while simultaneously performing surveillance cultures.
*Treat with azithromycin monotherapy due to pregnancy*
- **Azithromycin monotherapy** is contraindicated for gonorrhea treatment because it has a low barrier to resistance and would fail to cover chromosomal mutations affecting **efflux pumps (mtrR)**.
- While both drugs are safe in **pregnancy**, azithromycin must be used in **combination** with ceftriaxone to prevent treatment failure.
*Initiate spectinomycin therapy and routine partner notification only*
- **Spectinomycin** is a second-line agent that is currently not readily available in the United States and has poor efficacy for **pharyngeal infections**.
- Focusing only on routine notification ignores the critical **epidemiologic significance** of the Southeast Asian travel history associated with highly resistant strains.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
